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Background
Acute lymphoblastic leukemia (ALL) is the most common
childhood malignancy. With modern risk adapted multi-
modality therapy, the cure rates for pediatric ALL have
reached approximately 90%, but leukemia remains the
leading cause of cancer-related death in children and
outcomes for patients who relapse have not changed sub-
stantially over recent decades. Immunotherapy with donor
lymphocyte infusions for ALL has inferior responses
compared to other hematologic cancer types suggestive of
challenges inherent to immunologic targeting of ALL.
Blockage of immune checkpoint has led to advances in
treatment of solid tumors in clinic, but has not been fully
studied in leukemia models.
Methods
Using a transplantable murine model derived from
E2A-PBX1 transgenic mice we studied the impact of ALL
progression on T cell function in vivo, and also the impli-
cation of the blockage of the immune checkpoints.
Results
Vaccination protects mice against E2a-PBX1.3 and
requires T cells and NK cells. However, therapeutic vacci-
nation after ALL challenge is ineffective even when admi-
nistered early at a low disease burden. Adoptive transfer of
primed T cells from immunized donors can completely
eradicate the leukemia blast. Unfortunately, T cells from
leukemic mice fail to protect against E2a-PBX1.3 following
adoptive transfer. T cells from leukemic mice express the
programmed death receptor 1 (PD1) with progressive
accumulation of additional markers of T cell dysfunction
including LAG-3, and Tim-3. Furthermore, the expression
of PD-1 on the T cell from the tumor bearing mice is not
solely dependent on the TCR signaling. T cells from the
bone marrow of children with ALL also contained large
numbers of PD1+ T cells. Blockade of PD1 or its ligand,
PDL1, were ineffective at preventing E2aPBX1.3 progres-
sion. Finally, expression of a chimeric antigen receptor
targeting CD19 in T cells from leukemic mice fails to
restore function while the T cells from naïve mice can
completely cure the receipts.
Conclusions
These findings have important implications for the optimi-
zation of immunotherapy for ALL including adoptive cell
therapies utilizing CAR-expressing T cells when generated
from donors with leukemia.
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